3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
NET
1
Gastrointestinal
1
Endocrine
1
Conditions
Carcinoma, Non-Small-Cell Lung
373
Neoplasms
323
Neoplasm Metastasis
286
Leukemia, Myeloid, Acute
277
Breast Neoplasms
271
Colorectal Neoplasms
238
Melanoma
193
Ovarian Neoplasms
191
Recurrence
183
Multiple Myeloma
178
Prostatic Neoplasms
156
Lung Neoplasms
156
Pancreatic Neoplasms
152
Squamous Cell Carcinoma of Head and Neck
150
Lymphoma, Non-Hodgkin
146
Glioblastoma
145
Triple Negative Breast Neoplasms
119
Myelodysplastic Syndromes
114
Carcinoma, Renal Cell
111
Stomach Neoplasms
110
Glioma
108
Brain Neoplasms
105
Advanced Solid Tumors
104
Precursor Cell Lymphoblastic Leukemia-Lymphoma
103
Lymphoma, Large B-Cell, Diffuse
101
Lymphoma
100
Lymphoma, B-Cell
97
Carcinoma, Hepatocellular
95
Endometrial Neoplasms
92
Lymphoma, Follicular
91
Interventions
lanreotide
1
Octreotide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Acromegaly
×
1 year
×
Clear all
NCT05364944
2025-11-17
OXTEND-01
Debiopharm International SA
Phase 1
Terminated
19 enrolled